Filter News
Area of Research
News Topics
- (-) Biotechnology (2)
- (-) Climate Change (9)
- (-) Energy Storage (1)
- (-) Frontier (15)
- (-) Security (1)
- Artificial Intelligence (14)
- Big Data (3)
- Bioenergy (2)
- Biology (4)
- Biomedical (2)
- Chemical Sciences (1)
- Computer Science (11)
- Coronavirus (1)
- Critical Materials (1)
- Cybersecurity (1)
- Decarbonization (2)
- Environment (5)
- Exascale Computing (12)
- High-Performance Computing (18)
- Machine Learning (4)
- Materials (5)
- Microscopy (1)
- Nanotechnology (2)
- National Security (3)
- Net Zero (1)
- Neutron Science (1)
- Nuclear Energy (1)
- Physics (1)
- Quantum Computing (7)
- Quantum Science (4)
- Simulation (9)
- Software (1)
- Summit (6)
- Sustainable Energy (1)
- Transportation (1)
Media Contacts
The Oak Ridge Leadership Computing Facility’s Matt Sieger has been named the project director for the OLCF-6 effort. This next OLCF undertaking will plan and build a world-class successor to the OLCF’s still-new exascale system, Frontier.
With the world’s first exascale supercomputing system now open to full user operations, research teams are harnessing Frontier’s power and speed to tackle some of the most challenging problems in modern science.
A trio of new and improved cosmological simulation codes was unveiled in a series of presentations at the annual April Meeting of the American Physical Society in Minneapolis.
Oak Ridge National Laboratory, in partnership with the National Oceanic and Atmospheric Administration, is launching a new supercomputer dedicated to climate science research. The new system is the fifth supercomputer to be installed and run by the National Climate-Computing Research Center at ORNL.
ORNL has named Michael Parks director of the Computer Science and Mathematics Division within ORNL’s Computing and Computational Sciences Directorate. His hiring became effective March 13.
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.